In the news

Read how the AGENT™ Drug Coated Balloon — now available in the U.S. — addresses a critical unmet need for in-stent restenosis (ISR) treatment, using tech that represents a “quantum leap” forward.

A recent survey highlights that women are seeking new ways to lose weight, as Boston Scientific launches Endura Weight Loss Solutions to increase awareness of minimally invasive weight loss procedures.

At STAT’s AI-focused Breakthrough Summit West, Ken Stein, MD, senior vice president and global chief medical officer, shares how artificial intelligence is helping cardiologists make the leap from available insights to actionable ones.

At DeviceTalks Minnesota, Ken Stein, MD, senior vice president and global chief medical officer, outlines the steps Boston Scientific takes to evaluate a market, choose a development approach and establish the groundwork for adoption.

CEO Mike Mahoney shares lessons learned over his career that helped him shape Boston Scientific's winning culture and drive the company’s growth.